First Light Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Light Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-53,484	Closed	-$8.79M	–	81
2021 Q1	$8.79M	Buy	53,484 +1,522	+3%	+$250K	0.58%	43
2020 Q4	$8.58M	Buy	51,962 +796	+2%	+$119K	0.63%	36
2020 Q3	$7.3M	Buy	+51,166	New	+$6.34M	0.75%	34

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Light Asset Management's JAZZ Position: Q2 2021 in Review

First Light Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 53,484 shares — an estimated $8.79M sold.

First Light Asset Management first reported a position in JAZZ in Q3 2020 and held it in 3 quarters. The position peaked at $8.79M in Q1 2021. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

First Light Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
First Light Asset Management sold 53,484 Jazz Pharmaceuticals shares in Q2 2021, an estimated $8.79M.
First Light Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 3 quarters.
First Light Asset Management's Jazz Pharmaceuticals position peaked at $8.79M in Q1 2021.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.